Tumor evolution: Linear, branching, neutral or punctuated?
暂无分享,去创建一个
[1] C. Maley,et al. Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .
[2] Xuemei Lu,et al. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution , 2015, Proceedings of the National Academy of Sciences.
[3] N. Carter,et al. Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.
[4] A multitype infinite-allele branching process with applications to cancer evolution , 2015, Journal of Applied Probability.
[5] Martin A. Nowak,et al. A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity , 2015, Nature.
[6] P. Fialkow. The origin and development of human tumors studied with cell markers. , 1974, The New England journal of medicine.
[7] D. Santini,et al. Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH. , 2001, Cytometry.
[8] C. Swanton,et al. Can oncology recapitulate paleontology? Lessons from species extinctions , 2015, Nature Reviews Clinical Oncology.
[9] Marek Kimmel,et al. Branching processes in biology , 2002 .
[10] H. Ohtsuki,et al. Accumulation of driver and passenger mutations during tumor progression , 2009, Proceedings of the National Academy of Sciences.
[11] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[12] S. Kopetz,et al. The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men , 2012, Clinical Cancer Research.
[13] B. Kermani,et al. Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA , 2015, PloS one.
[14] Robert J Gillies,et al. Glycolysis in cancer: a potential target for therapy. , 2007, The international journal of biochemistry & cell biology.
[15] Irmtraud M. Meyer,et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.
[16] Kenny Q. Ye,et al. Novel patterns of genome rearrangement and their association with survival in breast cancer. , 2006, Genome research.
[17] N. Navin,et al. Advances and applications of single-cell sequencing technologies. , 2015, Molecular cell.
[18] Sridhar Ramaswamy,et al. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.
[19] Nilgun Donmez,et al. Clonality inference in multiple tumor samples using phylogeny , 2015, Bioinform..
[20] Xiaohong Li,et al. A Comprehensive Survey of Clonal Diversity Measures in Barrett's Esophagus as Biomarkers of Progression to Esophageal Adenocarcinoma , 2010, Cancer Prevention Research.
[21] W. Koh,et al. Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics , 2014, Proceedings of the National Academy of Sciences.
[22] Funda Meric-Bernstam,et al. Punctuated Copy Number Evolution and Clonal Stasis in Triple-Negative Breast Cancer , 2016, Nature Genetics.
[23] M. Jimenez-Linan,et al. Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer , 2010, British Journal of Cancer.
[24] N. Eldredge,et al. Punctuated equilibrium comes of age , 1993, Nature.
[25] M. Kimura. The number of heterozygous nucleotide sites maintained in a finite population due to steady flux of mutations. , 1969, Genetics.
[26] R. Solé,et al. Metapopulation dynamics and spatial heterogeneity in cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] P. Fialkow. Human genetic markers as tracers of tumour histogenesis , 1974, Journal of clinical pathology. Supplement.
[28] X. Xie,et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients , 2013, Proceedings of the National Academy of Sciences.
[29] Yoshitaka Narita,et al. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. , 2010, Genes & development.
[30] James D. Brenton,et al. Phylogenetic Quantification of Intra-tumour Heterogeneity , 2013, PLoS Comput. Biol..
[31] Robin L. Jones,et al. Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity. , 2014, Cell reports.
[32] Barbara L Parsons,et al. Many different tumor types have polyclonal tumor origin: evidence and implications. , 2008, Mutation research.
[33] Charles Swanton,et al. Intratumor Heterogeneity: Seeing the Wood for the Trees , 2012, Science Translational Medicine.
[34] Cheng-Zhong Zhang,et al. Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements , 2013, Genes & development.
[35] A. Bouchard-Côté,et al. PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.
[36] Faraz Hach,et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer , 2015, Nature Genetics.
[37] Cheng-Zhong Zhang,et al. Chromothripsis: A New Mechanism for Rapid Karyotype Evolution. , 2015, Annual review of genetics.
[38] O. Scharovsky,et al. Metronomic chemotherapy: changing the paradigm that more is better , 2009, Current oncology.
[39] K. Polyak,et al. Non-cell autonomous tumor-growth driving supports sub-clonal heterogeneity , 2014, Nature.
[40] A. Tward,et al. High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma , 2013, Cancer.
[41] Alexandre Bouchard-Côté,et al. Clonal genotype and population structure inference from single-cell tumor sequencing , 2016, Nature Methods.
[42] Y. Iwasa,et al. Evolutionary Dynamics of Intratumor Heterogeneity , 2011, PloS one.
[43] K. Polyak,et al. Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.
[44] Subramanian Venkatesan,et al. Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[45] Benjamin J. Raphael,et al. Reconstruction of clonal trees and tumor composition from multi-sample sequencing data , 2015, Bioinform..
[46] F. Waldman,et al. ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer. , 1995, Cancer research.
[47] Nicholas J. Wang,et al. Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease , 2015, PloS one.
[48] Huanming Yang,et al. Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancer , 2012, GigaScience.
[49] Ann M. Bailey,et al. Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[50] J. Bielas,et al. Mutator phenotype in cancer: Timing and perspectives , 2005, Environmental and molecular mutagenesis.
[51] Frida Rosengren,et al. Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma. , 2016, Cancer research.
[52] R. Gillies,et al. Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer , 2016, Science Translational Medicine.
[53] Yu Cao,et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing , 2014, Science.
[54] Carlo C. Maley,et al. Clonal evolution in cancer , 2012, Nature.
[55] E. Letouzé,et al. Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis , 2010, Genome Biology.
[56] N. André,et al. Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch , 2014, Front. Oncol..
[57] Carlos Caldas,et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer , 2015, Nature Communications.
[58] I. Fidler,et al. Tumor heterogeneity and the biology of cancer invasion and metastasis. , 1978, Cancer research.
[59] L. Pusztai,et al. Cancer heterogeneity: implications for targeted therapeutics , 2013, British Journal of Cancer.
[60] M. Nowak,et al. Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.
[61] Marc J. Williams,et al. Identification of neutral tumor evolution across cancer types , 2016, Nature Genetics.
[62] Joshua F. McMichael,et al. Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.
[63] C. Thompson,et al. Therapeutic targets in cancer cell metabolism and autophagy , 2012, Nature Biotechnology.
[64] Manuel Hidalgo,et al. Patient-derived xenograft models: an emerging platform for translational cancer research. , 2014, Cancer discovery.
[65] X. Xie,et al. Genome-Wide Detection of Single-Nucleotide and Copy-Number Variations of a Single Human Cell , 2012, Science.
[66] M. Choti,et al. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies , 2014, Science Translational Medicine.
[67] Markus J. van Roosmalen,et al. Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer , 2011, Genome Biology.
[68] S. Gestl,et al. Tumor cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers , 2014, Nature.
[69] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[70] Eric S. Lander,et al. The genomic complexity of primary human prostate cancer , 2010, Nature.
[71] Francesco Falciani,et al. DNA Microarrays: a Powerful Genomic Tool for Biomedical and Clinical Research , 2007, Molecular medicine.
[72] D. Pellman. Cell biology: Aneuploidy and cancer , 2007, Nature.
[73] A. Sidow,et al. Concepts in solid tumor evolution. , 2015, Trends in genetics : TIG.
[74] Rick Durrett. Cancer modelling: a personal perspective , 2013 .
[75] Robert E. Brown,et al. Field effect in cancer-an update. , 2009, Annals of clinical and laboratory science.
[76] M. Kimura. Rare variant alleles in the light of the neutral theory. , 1983, Molecular biology and evolution.
[77] V. P. Collins,et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.
[78] N. Navin,et al. Clonal Evolution in Breast Cancer Revealed by Single Nucleus Genome Sequencing , 2014, Nature.
[79] Le Zhang,et al. Simulating brain tumor heterogeneity with a multiscale agent-based model: Linking molecular signatures, phenotypes and expansion rate , 2006, Math. Comput. Model..
[80] Aviv Regev,et al. Whole exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer , 2014, Nature Biotechnology.
[81] R. DePinho,et al. Cancer chromosomes in crisis , 2004, Nature Genetics.
[82] M Kimmel,et al. Mathematical models of gene amplification with applications to cellular drug resistance and tumorigenicity. , 1990, Genetics.
[83] Joshua F. McMichael,et al. Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.
[84] J. Troge,et al. Tumour evolution inferred by single-cell sequencing , 2011, Nature.
[85] J. Troge,et al. Inferring tumor progression from genomic heterogeneity. , 2010, Genome research.
[86] Edward T. Bullmore,et al. The Multilayer Connectome of Caenorhabditis elegans , 2016, PLoS Comput. Biol..
[87] G. Bepler,et al. Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer , 2006, Clinical Cancer Research.
[88] Ash A. Alizadeh,et al. Toward understanding and exploiting tumor heterogeneity , 2015, Nature Medicine.
[89] Ash A. Alizadeh,et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage , 2013, Nature Medicine.
[90] Florian Markowetz,et al. OncoNEM: inferring tumor evolution from single-cell sequencing data , 2016, Genome Biology.
[91] Joel s. Brown,et al. Evolutionary dynamics in cancer therapy. , 2011, Molecular pharmaceutics.
[92] S. Noguchi,et al. Clonal analysis of human gynecologic cancers by means of the polymerase chain reaction , 1994, International journal of cancer.
[93] Huanming Yang,et al. Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor , 2012, Cell.
[94] Serafim Batzoglou,et al. Genome evolution during progression to breast cancer , 2013, Genome research.
[95] David A Kessler,et al. Resistance to chemotherapy: patient variability and cellular heterogeneity. , 2014, Cancer research.
[96] Niko Beerenwinkel,et al. BitPhylogeny: a probabilistic framework for reconstructing intra-tumor phylogenies , 2015, Genome Biology.
[97] Matthew Meyerson,et al. CHROMOTHRIPSIS FROM DNA DAMAGE IN MICRONUCLEI , 2015, Nature.
[98] Modeling neutral evolution using an infinite-allele Markov branching process , 2013 .
[99] Franziska Michor,et al. Intratumor Heterogeneity in Evolutionary Models of Tumor Progression , 2011, Genetics.
[100] Obi L. Griffith,et al. SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution , 2014, PLoS Comput. Biol..
[101] C. Swanton,et al. Re-Evaluating Clonal Dominance in Cancer Evolution. , 2016, Trends in cancer.
[102] Tae-Min Kim,et al. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity , 2015, Clinical Cancer Research.
[103] Huanming Yang,et al. Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm , 2012, Cell.
[104] K. Korolev,et al. Genetic demixing and evolution in linear stepping stone models. , 2010, Reviews of modern physics.
[105] S. Nelson,et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation , 2010, Nature.
[106] N. McGranahan,et al. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. , 2015, Cancer cell.
[107] M. Stratton,et al. High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.
[108] J. Troge,et al. High-resolution ROMA CGH and FISH analysis of aneuploid and diploid breast tumors. , 2005, Cold Spring Harbor symposia on quantitative biology.
[109] J. Mosser,et al. ‘From the core to beyond the margin’: a genomic picture of glioblastoma intratumor heterogeneity , 2014, Oncotarget.
[110] Carlos Caldas,et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. , 2013, The New England journal of medicine.
[111] Sohrab P. Shah,et al. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution , 2014, Nature.
[112] F. Michor,et al. Stochastic dynamics of cancer initiation , 2011, Physical biology.
[113] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[114] Y. Kluger,et al. TrAp: a tree approach for fingerprinting subclonal tumor composition , 2013, Nucleic acids research.
[115] P. A. P. Moran,et al. Random processes in genetics , 1958, Mathematical Proceedings of the Cambridge Philosophical Society.
[116] Robert S. Kerbel,et al. The anti-angiogenic basis of metronomic chemotherapy , 2004, Nature Reviews Cancer.
[117] M. Loda,et al. Establishment and genomic characterization of mouse xenografts of human primary prostate tumors. , 2010, The American journal of pathology.
[118] Martin A. Nowak,et al. Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution , 2016, PLoS Comput. Biol..
[119] Ali Bashashati,et al. Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer , 2016, Nature Genetics.
[120] Ali Bashashati,et al. Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling , 2013, The Journal of pathology.
[121] H. Koyama,et al. Clonal analysis of human breast cancer by means of the polymerase chain reaction. , 1992, Cancer research.
[122] Jian Wang,et al. Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing , 2014, Cell Research.
[123] Franziska Michor,et al. The Origins and Implications of Intratumor Heterogeneity , 2010, Cancer Prevention Research.
[124] S. Corey,et al. Stochastic Hypothesis of Transition from Inborn Neutropenia to AML: Interactions of Cell Population Dynamics and Population Genetics , 2013, Front. Oncol..
[125] M. Kimmel,et al. New explicit expressions for relative frequencies of single-nucleotide polymorphisms with application to statistical inference on population growth. , 2003, Genetics.
[126] A. Sivachenko,et al. Punctuated Evolution of Prostate Cancer Genomes , 2013, Cell.
[127] Shankar Vembu,et al. PhyloWGS: Reconstructing subclonal composition and evolution from whole-genome sequencing of tumors , 2015, Genome Biology.
[128] L. Loeb,et al. Human cancers express mutator phenotypes: origin, consequences and targeting , 2011, Nature Reviews Cancer.
[129] Joon-Oh Park,et al. MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling , 2007, Science.
[130] S. Gartler,et al. Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas , 1965, Science.
[131] O. Hallatschek,et al. Interfering Waves of Adaptation Promote Spatial Mixing , 2011, Genetics.
[132] Joshy George,et al. Whole–genome characterization of chemoresistant ovarian cancer , 2015, Nature.
[133] Iman Hajirasouliha,et al. A combinatorial approach for analyzing intra-tumor heterogeneity from high-throughput sequencing data , 2014, Bioinform..
[134] M. Stratton,et al. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing , 2008, Proceedings of the National Academy of Sciences.
[135] Elaine R. Mardis,et al. A decade’s perspective on DNA sequencing technology , 2011, Nature.
[136] Martin A. Nowak,et al. Genetic Progression and the Waiting Time to Cancer , 2007, PLoS Comput. Biol..
[137] David M. Thomas,et al. Next-Generation Sequence Analysis of Cancer Xenograft Models , 2013, PloS one.
[138] C. Curtis,et al. Many private mutations originate from the first few divisions of a human colorectal adenoma , 2015, The Journal of pathology.
[139] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[140] Andrew Menzies,et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing , 2015, Nature Medicine.
[141] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[142] Robert A Gatenby,et al. Application of Evolutionary Principles to Cancer Therapy. , 2015, Cancer research.
[143] Arun K. Ramani,et al. Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics , 2016, Acta Neuropathologica Communications.
[144] Z. Szallasi,et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.
[145] S. Rosenberg. Evolving responsively: adaptive mutation , 2001, Nature Reviews Genetics.
[146] Iman Hajirasouliha,et al. Fast and scalable inference of multi-sample cancer lineages , 2014, Genome Biology.
[147] Rick Durrett,et al. POPULATION GENETICS OF NEUTRAL MUTATIONS IN EXPONENTIALLY GROWING CANCER CELL POPULATIONS. , 2013, The annals of applied probability : an official journal of the Institute of Mathematical Statistics.
[148] David Allard,et al. Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.
[149] Alex M. Fichtenholtz,et al. Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting. , 2016, Blood.
[150] R. Orecchia,et al. Intratumor heterogeneity of chromosome 1, 7, 17, and 18 aneusomies obtained by FISH and association with flow cytometric DNA index in human colorectal adenocarcinomas. , 1999, Cytometry.
[151] S. Gabriel,et al. Advances in understanding cancer genomes through second-generation sequencing , 2010, Nature Reviews Genetics.
[152] David Pellman,et al. Causes and consequences of aneuploidy in cancer , 2012, Nature Reviews Genetics.
[153] James Hicks,et al. Tracing the tumor lineage , 2010, Molecular oncology.
[154] Robert A Gatenby,et al. Evolutionary Strategy for Systemic Therapy of Metastatic Breast Cancer: Balancing Response with Suppression of Resistance , 2014, Women's health.
[155] Gabor T. Marth,et al. SubcloneSeeker: a computational framework for reconstructing tumor clone structure for cancer variant interpretation and prioritization , 2014, Genome Biology.
[156] E. Freese. On the evolution of the base composition of DNA , 1962 .
[157] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[158] C. Curtis,et al. A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.
[159] N. Navin. Cancer genomics: one cell at a time , 2014, Genome Biology.
[160] P. A. Futreal,et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing , 2014, Nature Genetics.
[161] Shankar Vembu,et al. Inferring clonal evolution of tumors from single nucleotide somatic mutations , 2012, BMC Bioinformatics.
[162] Mark Cobbold,et al. Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study , 2014, PLoS biology.